European equities traded in the US as American depositary receipts were moving higher late Friday morning, up 0.48% to 1,412.34 on the S&P Europe Select ADR Index, which is relatively flat for the week.
From continental Europe, the gainers were led by internet browser company Opera (OPRA) and biopharmaceutical company Genfit (GNFT), which rose 6.8% and 2.5%, respectively. They were followed by 3D printer company Materialise (MTLS) and biotech firm BioNTech (BNTX), which were up 2.4% and 1.4%, respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and biotech firm Evaxion Biotech (EVAX), which fell 7.8% and 5.1%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and oil and gas company Eni (E), which were down 1.5% and 1.3%, respectively.
From the UK and Ireland, the gainers were led by alcoholic beverage company Diageo (DEO) and financial services company Barclays (BCS), which increased 2% each. They were followed by financial services company HSBC (HSBC) and cruise line operator Carnival (CUK), which were up 1.5% each.
The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and pharmaceutical company Silence Therapeutics (SLN), which dropped 4.1% and 3.7%, respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company TC Biopharm (TCBP), which lost 3.1% and 2.8%, respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。